Sign In
Buy ESTA
$92.54
-0.94 (-1.01%)
At Close: Jul 31, 2026
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates
10:16am, Wednesday, 05'th Nov 2025
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.59 per share a year ago.
Establishment Labs Reports Third Quarter 2025 Financial Results
08:00am, Wednesday, 05'th Nov 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Given Consensus Rating of “Moderate Buy” by Analysts
01:40am, Friday, 31'st Oct 2025
Shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the company
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5
08:00am, Wednesday, 22'nd Oct 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal
08:00am, Tuesday, 14'th Oct 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report
08:00am, Thursday, 09'th Oct 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Holdings Inc. (ESTA) Q2 2025 Earnings Call Transcript
02:20am, Friday, 08'th Aug 2025
Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Fillipo Peter Caldini - CEO & Director Rajbir Singh Denhoy - Chief Finan
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Misses Revenue Estimates
10:16am, Thursday, 07'th Aug 2025
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.62 per share a year ago.
Establishment Labs Reports Second Quarter 2025 Financial Results
08:00am, Thursday, 07'th Aug 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7
08:00am, Friday, 25'th Jul 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Hosting Investor Day on June 12
07:07pm, Wednesday, 11'th Jun 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs to Present at Jefferies Global Healthcare Conference
04:30pm, Tuesday, 03'rd Jun 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Holdings, Inc. (ESTA) Q1 2025 Earnings Call Transcript
09:29pm, Saturday, 10'th May 2025
Establishment Labs Holdings, Inc. (NASDAQ:ESTA ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Peter Caldini - Chief Executive Officer Rajbir Denhoy - Chief Financial Of
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Lags Revenue Estimates
06:10pm, Wednesday, 07'th May 2025
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.70 per share versus the Zacks Consensus Estimate of a loss of $0.83. This compares to loss of $0.58 per share a year ago.
Establishment Labs Reports First Quarter 2025 Financial Results
04:00pm, Wednesday, 07'th May 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
